Real-world experiences of switching to subcutaneous formulation in IBD patients on maintenance vedolizumab treatment

P. Bacsur, T. Resal, B. Farkas, P. Sarlos, A. Ilias, D. Kata, A. Balint, A. Fabian, R. Bor, Z. Szepes, T. Molnar, K. Farkas

JOURNAL OF CROHNS & COLITIS（2024）

Cited 0|Views6

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined